Skopos Labs, Inc. Y M Abs Therapeutics, Inc. Transaction History
Skopos Labs, Inc.
- $813 Million
- Q3 2025
A detailed history of Skopos Labs, Inc. transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 16,061 shares of YMAB stock, worth $138,285. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,061Holding current value
$138,285% of portfolio
0.02%Shares
4 transactions
Others Institutions Holding YMAB
# of Institutions
8Shares Held
3.29MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.94MShares$25.3 Million0.0% of portfolio
-
Memorial Sloan Kettering Cancer Center New York, NY191KShares$1.65 Million4.24% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL112KShares$968,4780.0% of portfolio
-
Ziegler Capital Management, LLC35.5KShares$305,3190.02% of portfolio
-
Ifp Advisors, Inc334Shares$2,8750.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $376M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...